There seems to be a headway in the fight against the COVID-19 pandemic as Russia has completed the first ever clinical trials of vaccine on humans.
This is even as a report has claimed that the vaccines have proven to be effective among volunteers they were used on.
Announcing the development Monday, the Chief Researcher and Head, Centre for Clinical Research on Medications, Sechenov University, Russia, Elena Smolyarchuk, said those who featured in the human trial will be discharged soon.
He said: “The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20.”
There was no other information on when this vaccine would enter commercial production.
Russia had allowed clinical trials of two forms of a potential COVID-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology.
The first one was carried out at the Burdenko Military Hospital, while the other vaccine was given to COVID-19 patients at the Sechenov First Moscow State Medical University.
He explained that: “Some 20 people volunteered for the injection. After given the shot, the volunteers were asked to quarantine in the hospital for 28 days.”
Earlier, results of the COVID-19 vaccine tests performed on a group of volunteers in Russia showed that they were developing immunity to the coronavirus, but what the actual composition of the drug was not explained.
There are at least 21 vaccines currently under trial worldwide, according to the World Health Organisation (WHO). Every country and every laboratory is taking a different approach to finding the right solution to stop the virus from taking over the world.
Russia has reported 719,449 cases of COVID-19. Some 11,188 people have died from complications caused by the disease.
This is even as a report has claimed that the vaccines have proven to be effective among volunteers they were used on.
Announcing the development Monday, the Chief Researcher and Head, Centre for Clinical Research on Medications, Sechenov University, Russia, Elena Smolyarchuk, said those who featured in the human trial will be discharged soon.
He said: “The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20.”
There was no other information on when this vaccine would enter commercial production.
Russia had allowed clinical trials of two forms of a potential COVID-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology.
The first one was carried out at the Burdenko Military Hospital, while the other vaccine was given to COVID-19 patients at the Sechenov First Moscow State Medical University.
He explained that: “Some 20 people volunteered for the injection. After given the shot, the volunteers were asked to quarantine in the hospital for 28 days.”
Earlier, results of the COVID-19 vaccine tests performed on a group of volunteers in Russia showed that they were developing immunity to the coronavirus, but what the actual composition of the drug was not explained.
There are at least 21 vaccines currently under trial worldwide, according to the World Health Organisation (WHO). Every country and every laboratory is taking a different approach to finding the right solution to stop the virus from taking over the world.
Russia has reported 719,449 cases of COVID-19. Some 11,188 people have died from complications caused by the disease.
Thank you for reaching out to us. We are happy to receive your opinion and request. If you need advert or sponsored post, We’re excited you’re considering advertising or sponsoring a post on our blog. Your support is what keeps us going. With the current trend, it’s very obvious content marketing is the way to go. Banner advertising and trying to get customers through Google Adwords may get you customers but it has been proven beyond doubt that Content Marketing has more lasting benefits.
We offer majorly two types of advertising:
1. Sponsored Posts: If you are really interested in publishing a sponsored post or a press release, video content, advertorial or any other kind of sponsored post, then you are at the right place.
WHAT KIND OF SPONSORED POSTS DO WE ACCEPT?
Generally, a sponsored post can be any of the following:
Press release
Advertorial
Video content
Article
Interview
This kind of post is usually written to promote you or your business. However, we do prefer posts that naturally flow with the site’s general content. This means we can also promote artists, songs, cosmetic products and things that you love of all products or services.
DURATION & BONUSES
Every sponsored article will remain live on the site as long as this website exists. The duration is indefinite! Again, we will share your post on our social media channels and our email subscribers too will get to read your article. You’re exposing your article to our: Twitter followers, Facebook fans and other social networks.
We will also try as much as possible to optimize your post for search engines as well.
Submission of Materials : Sponsored post should be well written in English language and all materials must be delivered via electronic medium. All sponsored posts must be delivered via electronic version, either on disk or e-mail on Microsoft Word unless otherwise noted.
PRICING
The price largely depends on if you’re writing the content or we’re to do that. But if your are writing the content, it is $60 per article.
2. Banner Advertising: We also offer banner advertising in various sizes and of course, our prices are flexible. you may choose to for the weekly rate or simply buy your desired number of impressions.
Technical Details And Pricing
Banner Size 300 X 250 pixels : Appears on the home page and below all pages on the site.
Banner Size 728 X 90 pixels: Appears on the top right Corner of the homepage and all pages on the site.
Large rectangle Banner Size (336x280) : Appears on the home page and below all pages on the site.
Small square (200x200) : Appears on the right side of the home page and all pages on the site.
Half page (300x600) : Appears on the right side of the home page and all pages on the site.
Portrait (300x1050) : Appears on the right side of the home page and all pages on the site.
Billboard (970x250) : Appears on the home page.
Submission of Materials : Banner ads can be in jpeg, jpg and gif format. All materials must be deliverd via electronic medium. All ads must be delivered via electronic version, either on disk or e-mail in the ordered pixel dimensions unless otherwise noted.
For advertising offers, send an email with your name,company, website, country and advert or sponsored post you want to appear on our website to advert @ alexa. ng
Normally, we should respond within 48 hours.